Discontinuation versus continuation of hypertonic saline or dornase alfa in modulator treated people with cystic fibrosis (SIMPLIFY): results from two parallel, multicentre, open-label, randomised, controlled, non-inferiority trials
- Resource Type
- Article
- Source
- The Lancet Respiratory Medicine; April 2023, Vol. 11 Issue: 4 p329-340, 12p
- Subject
- Language
- ISSN
- 22132600; 22132619